Nurix Therapeutics, Inc. (NRIX)
22.14
-0.21
(-0.94%)
USD |
NASDAQ |
Oct 12, 16:00
22.52
+0.38
(+1.72%)
After-Hours: 19:33
Nurix Therapeutics Market Cap : 2.296B for Oct. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 2.318B |
| October 08, 2026 | 2.303B |
| October 07, 2026 | 2.357B |
| October 06, 2026 | 2.344B |
| October 05, 2026 | 2.373B |
| October 02, 2026 | 2.384B |
| October 01, 2026 | 2.420B |
| September 30, 2026 | 2.459B |
| September 29, 2026 | 2.455B |
| September 28, 2026 | 2.455B |
| September 25, 2026 | 2.386B |
| September 24, 2026 | 2.453B |
| September 23, 2026 | 2.476B |
| September 22, 2026 | 2.662B |
| September 21, 2026 | 2.635B |
| September 18, 2026 | 2.638B |
| September 17, 2026 | 2.644B |
| September 16, 2026 | 2.608B |
| September 15, 2026 | 2.575B |
| September 14, 2026 | 2.646B |
| September 11, 2026 | 2.603B |
| September 10, 2026 | 2.677B |
| September 09, 2026 | 2.723B |
| September 08, 2026 | 2.710B |
| September 04, 2026 | 2.711B |
| Date | Value |
|---|---|
| September 03, 2026 | 2.626B |
| September 02, 2026 | 2.678B |
| September 01, 2026 | 2.700B |
| August 31, 2026 | 2.673B |
| August 28, 2026 | 2.718B |
| August 27, 2026 | 2.787B |
| August 26, 2026 | 2.770B |
| August 25, 2026 | 2.795B |
| August 24, 2026 | 2.724B |
| August 21, 2026 | 2.771B |
| August 20, 2026 | 2.805B |
| August 19, 2026 | 2.882B |
| August 18, 2026 | 2.793B |
| August 17, 2026 | 2.818B |
| August 14, 2026 | 2.805B |
| August 13, 2026 | 2.820B |
| August 12, 2026 | 2.762B |
| August 11, 2026 | 2.692B |
| August 10, 2026 | 2.684B |
| August 07, 2026 | 2.647B |
| August 06, 2026 | 2.615B |
| August 05, 2026 | 2.605B |
| August 04, 2026 | 2.560B |
| August 03, 2026 | 2.408B |
| July 31, 2026 | 2.407B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 186.70B |
| ACADIA Pharmaceuticals, Inc. | 3.341B |
| Alnylam Pharmaceuticals, Inc. | 30.36B |
| Anika Therapeutics, Inc. | 276.63M |
| Savara, Inc. | 993.11M |
Market Cap Related Metrics
| PS Ratio | 60.28 |
| PEG Ratio | -0.2008 |
| Price to Book Value | 5.702 |
| Price | 22.14 |
| Earnings Yield | -15.57% |
| PEGY Ratio | -0.2008 |